4.71

0.64% 0.03

Conexeu Sciences Inc (CNXU)

Overview News Price History Discussions Forecast

Conexeu Sciences Inc stock is traded at $4.71, with a volume of 85,254. It is up +0.64% in the last 24 hours and down -41.64% over the past month. Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Previous Close:

$4.68

Open:

$4.69

24h Volume:

85,254

Relative Volume:

0.53

Market Cap:

$126.03M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-15.29%

1M Performance:

-41.64%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$4.52

$4.82

1-Week Range:

$4.52

$5.7899

52-Week Range:

$4.52

$18.79

Conexeu Sciences Inc Stock (CNXU) Company Profile

Name

Conexeu Sciences Inc

Sector

Healthcare (1086)

Industry

Biotechnology (606)

Phone

604-315-4722

Address

50 WEST LIBERTY STREET, SUITE 880, RENO

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

CNXU's Discussions on Twitter

Compare CNXU vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CNXU Conexeu Sciences Inc	4.71	125.23M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	520.76	134.06B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.41	83.43B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,005.47	63.00B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	137.29	56.02B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.94	44.44B	742.00K	-1.37B	-1.07B	-7.0731

Conexeu Sciences Inc Stock (CNXU) Latest News

Sep 08, 2026

Conexeu Sciences (NASDAQ:CNXU) Shares Down 5.2%Here's What Happened - MarketBeat

Sep 04, 2026

Sep 01, 2026

A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture - Finansavisen

Sep 01, 2026

Conexeu Steps Up Investor Outreach Ahead of Key Regulatory Milestones - TipRanks

Sep 01, 2026

Conexeu Sciences Sets September and October 2026 Conference Schedule - The Manila Times

Sep 01, 2026

At Nasdaq headquarters, a biotech company will present Sept. 9, then attend two more events. - Stock Titan

Sep 01, 2026

Aug 31, 2026

Conexeu Sciences (CNXU) pays consultants with $88K in stock - Stock Titan

Aug 31, 2026

Aug 25, 2026

Here's Why We're Not Too Worried About Conexeu Sciences' (NASDAQ:CNXU) Cash Burn Situation - webull.com

Aug 25, 2026

Aug 21, 2026

Conexeu Sciences (CNXU) Insider Trading Activity 2026 - MarketBeat

Aug 21, 2026

The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts - Eastern Progress

Aug 21, 2026

Aug 18, 2026

A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It. - The Spec

Aug 18, 2026

The Biggest Winners Don't Compete in a Category. They Rewrite It. One Company Is Betting It Can Too. - marketscreener.com

Aug 18, 2026

Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration - Moomoo

Aug 18, 2026

Jeffrey Sharpe Discloses Investment at Conexeu Sciences Inc. with 5.4% Stake - TradingView

Aug 18, 2026

2.3M-share stake in Conexeu Sciences (CNXU) revealed by single investor - Stock Titan

Aug 18, 2026

Conexeu (CNXU) director gets $0.001 warrants tied to Nasdaq, FDA goals - Stock Titan

Aug 18, 2026

CNXU - Finviz

Aug 18, 2026

Aug 17, 2026